Bristol-Myers’ Opdivo nets the first PhIII gastric cancer win for checkpoint inhibitors

Bristol-Myers' Opdivo nets the first PhIII gastric cancer win for checkpoint inhibitors chelfand Thu, 11/10/2016 - 12:37…
Read the full story: Feed